MetaADEDB 2.0 @ LMMD
Formoterol Fumarate
(OBRNDARFFFHCGE-PERKLWIXSA-N)
Structure
SMILES
OC(=O)/C=C/C(=O)O.O=CNc1cc(ccc1O)[C@@H](CN[C@H](Cc1ccc(cc1)OC)C)O.O=CNc1cc(ccc1O)[C@@H](CN[C@H](Cc1ccc(cc1)OC)C)O
Molecular Formula:
C42H52N4O12
Molecular Weight:
804.882
Log P:
6.3580
Hydrogen Bond Acceptor:
16
Hydrogen Bond Donor:
10
TPSA:
256.24
CAS Number(s):
43229-80-7
Synonym(s)
1.
Formoterol Fumarate
2.
3-Formylamino-4-hydroxy-alpha-(N-1-methyl-2-p-methoxyphenethylaminomethyl)benzyl alcohol.hemifumarate
3.
Arformoterol
4.
BD 40A
5.
Eformoterol
6.
Foradil
7.
Formoterol
8.
Formoterol Fumarate, ((R*,R*)-(+-))-isomer
9.
Formoterol, ((R*,R*)-(+-))-isomer
10.
Oxis
External Link(s)
MeSHD000068759
PubChem Compound9832292
ChEBI63109
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AsthmaFAERS: 35

View details

CTD
US FAERS
2PneumoniaFAERS: 2920826145CTD
US FAERS
3MalaiseFAERS: 28US FAERS
4FatigueFAERS: 22US FAERS
5Device malfunctionFAERS: 16US FAERS
6BronchitisFAERS: 12US FAERS
7InfluenzaFAERS: 11US FAERS
8Cardiac ArrestFAERS: 10US FAERS
9Respiratory FailureFAERS: 10US FAERS
10Wrong technique in drug usage processFAERS: 10US FAERS
11InfarctionFAERS: 9US FAERS
12SyncopeFAERS: 9US FAERS
13TremorFAERS: 910516540CTD
US FAERS
14AstheniaFAERS: 8US FAERS
15Chest PainFAERS: 8US FAERS
16Diabetes MellitusFAERS: 7US FAERS
17Cerebrovascular accidentFAERS: 6US FAERS
18Increased bronchial secretionFAERS: 6US FAERS
19DizzinessFAERS: 5US FAERS
20Feeling abnormalFAERS: 5US FAERS
21HeadacheFAERS: 5US FAERS
22HypersensitivityFAERS: 5US FAERS
23Memory impairmentFAERS: 5US FAERS
24NervousnessFAERS: 5US FAERS
25PainFAERS: 5US FAERS
26Pulmonary EmbolismFAERS: 5US FAERS
27ThrombosisFAERS: 5US FAERS
28BronchospasmFAERS: 4US FAERS
29Capsule physical issueFAERS: 4US FAERS
30Drug DependenceFAERS: 4US FAERS
31Drug ineffectiveFAERS: 4
Canada Vigilance: 4
Canada Vigilance
US FAERS
32Incorrect route of drug administrationFAERS: 4US FAERS
33Increased upper airway secretionFAERS: 4US FAERS
34InfectionFAERS: 4US FAERS
35SinusitisFAERS: 4US FAERS
36Abdominal PainFAERS: 3US FAERS
37Acute respiratory failureFAERS: 3US FAERS
38Apparent deathFAERS: 3US FAERS
39CandidiasisFAERS: 3US FAERS
40Chest discomfortFAERS: 3US FAERS
41DeafnessFAERS: 3US FAERS
42DysphoniaFAERS: 3US FAERS
43FractureFAERS: 3US FAERS
44HyperthyroidismFAERS: 3US FAERS
45Medication ErrorFAERS: 3US FAERS
46Musculoskeletal PainFAERS: 3US FAERS
47NauseaFAERS: 3US FAERS
48Oropharyngeal painFAERS: 3US FAERS
49OsteoporosisFAERS: 3US FAERS
50Product quality issueFAERS: 3
Canada Vigilance: 4
Canada Vigilance
US FAERS
51SwellingFAERS: 3US FAERS
52TachycardiaFAERS: 3US FAERS
53Throat irritationFAERS: 3US FAERS
54TuberculosisFAERS: 3US FAERS
55VomitingFAERS: 3US FAERS
56WheezingFAERS: 3US FAERS
57Accidental drug intake by childFAERS: 2US FAERS
58Acute myocardial infarctionFAERS: 2US FAERS
59AneurysmFAERS: 2US FAERS
60AppendicitisFAERS: 2US FAERS
61Atrial FibrillationFAERS: 2US FAERS
62Back PainFAERS: 2US FAERS
63BedriddenFAERS: 2US FAERS
64Blood cholesterol increasedFAERS: 2US FAERS
65Blood glucose increasedFAERS: 2US FAERS
66Blood immunoglobulin E increasedFAERS: 2US FAERS
67BronchopneumoniaFAERS: 2US FAERS
68ChokingFAERS: 2US FAERS
69Depressed moodFAERS: 2US FAERS
70DiverticulitisFAERS: 2US FAERS
71Drug administration errorFAERS: 2US FAERS
72Drug dose omissionFAERS: 2US FAERS
73DysgeusiaFAERS: 2US FAERS
74Expired drug administeredFAERS: 2US FAERS
75GlaucomaFAERS: 2US FAERS
76HypophagiaFAERS: 2US FAERS
77Incorrect dose administeredFAERS: 2US FAERS
78Maternal exposure during pregnancyFAERS: 2US FAERS
79MonoplegiaFAERS: 2US FAERS
80NasopharyngitisFAERS: 2US FAERS
81No adverse eventFAERS: 2US FAERS
82Poor quality drug administeredFAERS: 2US FAERS
83Respiratory arrestFAERS: 2US FAERS
84Respiratory distressFAERS: 2US FAERS
85Respiratory tract congestionFAERS: 2US FAERS
86SomnolenceFAERS: 2US FAERS
87Weight decreasedFAERS: 2US FAERS
88Wheelchair userFAERS: 2US FAERS
89Wrong drug administeredFAERS: 2US FAERS
90AbasiaFAERS: 1US FAERS
91Abdominal discomfortFAERS: 1US FAERS
92Allergic bronchitisFAERS: 1US FAERS
93AngioedemaFAERS: 1US FAERS
94AnxietyFAERS: 1US FAERS
95AphoniaFAERS: 1US FAERS
96Aphthous StomatitisFAERS: 1US FAERS
97ArthropathyFAERS: 1US FAERS
98AspergillosisFAERS: 1US FAERS
99Atrial FlutterFAERS: 1US FAERS
100Blood potassium decreasedFAERS: 1US FAERS
101Blood pressure fluctuationFAERS: 1US FAERS
102Blood urine presentFAERS: 1US FAERS
103Bone SarcomaFAERS: 1US FAERS
104Bone erosionFAERS: 1US FAERS
105Bronchopulmonary diseaseFAERS: 1US FAERS
106Burning sensationFAERS: 1US FAERS
107Cataract operation complicationFAERS: 1US FAERS
108CataractFAERS: 1US FAERS
109Concomitant disease progressionFAERS: 1US FAERS
110CyanosisFAERS: 1US FAERS
111CystFAERS: 1US FAERS
112Delayed deliveryFAERS: 1US FAERS
113DependenceFAERS: 1US FAERS
114DermatitisFAERS: 1US FAERS
115DiscomfortFAERS: 1US FAERS
116Drug abuseFAERS: 1US FAERS
117Drug exposure during pregnancyFAERS: 1US FAERS
118DyspepsiaFAERS: 1US FAERS
119EpistaxisFAERS: 1US FAERS
120ErysipelasFAERS: 1US FAERS
121ErythemaFAERS: 1US FAERS
122FibrosisFAERS: 1US FAERS
123FlatulenceFAERS: 1US FAERS
124Foreign body traumaFAERS: 1US FAERS
125GangreneFAERS: 1US FAERS
126Gastric ulcerFAERS: 1US FAERS
127GastritisFAERS: 1US FAERS
128Gastrointestinal carcinomaFAERS: 1US FAERS
129Gastrointestinal hypomotilityFAERS: 1US FAERS
130Gastrointestinal infectionFAERS: 1US FAERS
131HungerFAERS: 1US FAERS
132HypotensionFAERS: 1US FAERS
133HypoxiaFAERS: 1US FAERS
134Incorrect dose administered by deviceFAERS: 1US FAERS
135Incorrect product storageFAERS: 1US FAERS
136InflammationFAERS: 1US FAERS
137Inspiratory capacity decreasedFAERS: 1US FAERS
138Joint injuryFAERS: 1US FAERS
139Joint swellingFAERS: 1US FAERS
140LabyrinthitisFAERS: 1US FAERS
141LaryngospasmFAERS: 1US FAERS
142LeukocytosisFAERS: 1US FAERS
143Ligament injuryFAERS: 1US FAERS
144Limb discomfortFAERS: 1US FAERS
145Lung hyperinflationFAERS: 1US FAERS
146Medication residueFAERS: 1US FAERS
147MetastasisFAERS: 1US FAERS
148Multiple SclerosisFAERS: 1US FAERS
149MyalgiaFAERS: 1US FAERS
150Myocardial InfarctionFAERS: 1US FAERS
151Nerve injuryFAERS: 1US FAERS
152Oral candidiasisFAERS: 1US FAERS
153OsteopeniaFAERS: 1US FAERS
154Poor peripheral circulationFAERS: 1US FAERS
155Product physical issueFAERS: 1US FAERS
156PruritusFAERS: 1US FAERS
157Pulmonary HypertensionFAERS: 1US FAERS
158Rheumatoid ArthritisFAERS: 1US FAERS
159Secretion dischargeFAERS: 1US FAERS
160Septic ShockFAERS: 1US FAERS
161ShockFAERS: 1US FAERS
162Subcutaneous EmphysemaFAERS: 1US FAERS
163TachyarrhythmiaFAERS: 1US FAERS
164Therapeutic response unexpectedFAERS: 1US FAERS
165TinnitusFAERS: 1US FAERS
166ToothacheFAERS: 1US FAERS
167UlcerFAERS: 1US FAERS
168Upper respiratory tract inflammationFAERS: 1US FAERS
169Visual ImpairmentFAERS: 1US FAERS
170Vitamin D DeficiencyFAERS: 1US FAERS
171nervous system disorderFAERS: 1US FAERS
172Bronchial Hyperreactivity17336541CTD
173Dyspnea22069361CTD
174Lung Injury25313925CTD
175Myocarditis16908771CTD
176Product dose omissionCanada Vigilance: 1Canada Vigilance
177Pulmonary Edema17336541CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.